Health & Biotech
Hygrovest Limited (“Hygrovest”) (ASX: HGV) is an Australian listed, specialist investment company that has traded on the ASX since 2015. Investors in Hygrovest gain exposure to a portfolio which concentrates on producing capital growth for shareholders over the medium to long term from investments in listed and unlisted equities and other financial assets.
Investments are managed by Parallax Ventures Inc., a specialist management company in Canada, under a longterm strategic partnership.
In December 2021 HGV changed to change its name to “Hygrovest Limited” from MMJ Group Holdings Limited. The ASX code has also changed from MMJ to HGV.
Since 2015, Hygrovest has created a significant number of investment opportunities from its connections in Canada and Australia in the private investment sector and realised exits to the benefit of Hygrovest and its shareholders.
RELATED STOCKHEAD STORIES
Health & Biotech
Weed Week: ‘Welcome to the psychedelic 2020s!’ as market holds breath on key US approval
Health & Biotech
Weed Week: Decriminalising cannabis could save Aussie tax payers billions every year
Explainers
ASX Cannabis Stocks Guide 2022/23: Here’s everything you need to know
News
Weed Week: New Yorkers with cannabis convictions first in line for retail licences, CBX Stock Exchange launches
Health & Biotech
Check up: 78 biotech companies rocked the boat this week but only one has real news
Health & Biotech
ASX Pot Stocks: MMJ invests $1 million in Weed Me, Creso plans US ImpACTIVE launch
Health & Biotech
Weed Week: The CanCoin, cannabis tourism, and record medicinal product sales in Australia
Stockhead TV
V-Con: Medical cannabis – green grass, green growth
Health & Biotech
The ASX pot stocks looking to get high on Canada’s $3bn market
News
North American pot stocks are on fire, Aussies still MIA
Health & Biotech
MMJ doubles down on EU cannabis extractor with big investment
Health & Biotech
Weed Week: Asking the big questions – what takes priority in a pandemic, cannabis or toilet paper?
Health & Biotech
Will 2021 be the recovery year for cannabis?
Health & Biotech
North Americans are stockpiling cannabis for COVID crackdowns and this could finally fix the market
Health & Biotech
MMJ Holdings stays flexible on capital strategy, offers improved terms to investors
Food & Agriculture
Health Kick Podcast: The strategy and upside behind global cannabis investment company MMJ
Health & Biotech